LakeShore Biopharma Co., Ltd. (LSBCF)
About LakeShore Biopharma Co., Ltd.
LAKESHORE BIOPHARMA CO
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $85.7M
- Net income
- -$13.9M
- Total assets
- $190.5M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
LakeShore Biopharma Co., Ltd. (LSBCF) Stock Price
- Reported a net loss of $13.9M in FY2025.
- Trading 92% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review LakeShore Biopharma Co., Ltd..
Write a review
News about LakeShore Biopharma Co., Ltd.
News & sentiment via Polygon.io
LakeShore Biopharma Co., Ltd.: frequently asked questions
Is LakeShore Biopharma Co., Ltd. an American company?
LakeShore Biopharma Co., Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is LakeShore Biopharma Co., Ltd. publicly traded?
Yes — LakeShore Biopharma Co., Ltd. is a publicly traded company. Its stock trades under the ticker symbol LSBCF on the OTC.
What does LakeShore Biopharma Co., Ltd. do?
LakeShore Biopharma Co., Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.
